Modulation of dopamine release in the nucleus accumbens by 5-HT(1B) agonists: Involvement of the hippocampo-accumbens pathway

Neuropharmacology

Volumn 35, Issue 11, 1996, Pages 1521-1529

  Boulenguez, P ^a   Rawlins, J N P ^b   Chauveau, J ^c   Joseph, M H ^a   Mitchell, S N ^d   Gray, J A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Immunotech   (France)

^d Sandoz Pharma Ltd   (Switzerland)

Author keywords

5 HT(1A) and 5 HT(1B) receptors; Fimbria fornix; Hippocampal formation; Microdialysis; Nucleus accumbens; Schizophrenia

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; DOPAMINE; HOMOVANILLIC ACID; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B AGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN AGONIST; SEROTONIN O CARBOXYMETHYL GLYCYLTYROSINAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE RELEASE; HIPPOCAMPUS; HISTOLOGY; INTRACEREBRAL DRUG ADMINISTRATION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MICRODIALYSIS; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SUBCUTANEOUS DRUG ADMINISTRATION; SUBICULUM;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; HIPPOCAMPUS; INDOLES; MALE; MICRODIALYSIS; MICROINJECTIONS; NEURAL PATHWAYS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGONISTS;

EID: 0030444234     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(96)00099-8     Document Type: Article

References (48)

1. Benloucif S. and Galloway M. P. (1991) Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur. J. Pharmacol. 200: 1-8.
2. Bleich A., Brow S.-L., Kahn R. and van Praag H. M. (1988) The role of serotonin in schizophrenia. Schiz. Bull. 14: 287-315.
3. Bogerts B. (1990) The neuropathology of schizophrenia. In: Search for the Causes of Schizophrenia (Häfner H. and Gattaz W. F., Eds), Vol. II. pp. 229-241. Springer Verlag, Berlin.
4. 1D binding sites. J. Pharmacol. Exp. Ther. 259: 1360-1365.
5. Boulenguez P., Joseph M. H., Gray J. A. and Mitchell S. N. (1993) Dopamine release in the nucleus accumbens after systemic and intrahippocampal injections of serotonin-1 agonists which differentially affected attention in the rat. Br. J. Pharmacol. (Suppl.) 111: 153P.
6. Boulenguez P., Mitchell S. N., Rawlins J. N. P., Chauveau J., Joseph M. H. and Gray J. A. (1994) Interactions between serotonin and dopamine in the hippocampo-accumbens pathway in relation to overattention in schizophrenia. In: Abstract Book of the 6th International Conference on in vivo Methods, Seignosse, France, 17-20 September.
7. Carlsson A. (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1: 179-203.
8. Cassaday H. J., Hodges H. and Gray J. A. (1993) The effect of ritanserin, RU 24969 and 8-OH-DPAT on latent inhibition in the rat. J. Psychopharmacol. 7: 63-71.
9. 1B ligand, cross the blood brain barrier? In: Meeting on Serotonin, Chicago, Abstr. No. 95.
10. 1B binding sites, Naunyn Schmiedeberg's Arch. Pharmacol. 332: 1-7.
11. Feldon J. and Rawlins J. N. P. (1985) Fornix-fimbria section and the partial reinforcement extinction effect. Exp. Brain Res. 58: 435-439.
12. Feldon J. and Weiner I. (1991) The latent inhibition model of schizophrenic attention disorder: haloperidol and sulpiride enhance rat's ability to ignore irrelevant stimuli. Biol. Psychiat. 29: 635-646.
13. Feldon J. and Weiner I. (1992) From an animal model of an attentional deficit toward new insights into the pathophysiology of schizophrenia. J. Psychiat. Res. 26: 345-366.
14. Fuller T. A., Russchen F. T. and Price J. L. (1987) Source of presumptive glutamatergic/aspartatergic afferents to the rat ventral striatopallidal region. J. Comp. Neurol. 258: 317-338.
15. Glennon R. A. (1990) Serotonin receptors: clinical implications. Neurosci. Biobehav. Rev. 14: 35-47.
16. Grace A. A. (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41: 1-24.
17. Gray J. A., Feldon J., Rawlins J. N. P., Hemsley D. R. and Smith A. D. (1991) The neuropsychology of schizophrenia. Behav. Brain Sci. 14: 1-84.
18. Gray J. A., Joseph M. H., Hemsley D. R., Young A. M. J., Warburton C., Boulenguez P., Gregoryan G. A., Peters S. L., Rawlins J. N. P., Tai C. T., Yee B. K., Cassaday H., Weiner I., Gal G., Gusak O., Joel D., Shadrach E., Shalev U., Tarrasch R. and Feldon J. (1995) The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. Behav. Brain Rev. 71: 19-31.
19. Gray N. S., Hemsley D. R. and Gray J. A. (1992) Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurol. Psychiat. Brain Res. 1: 83-89.
20. Gray N. S., Pilowsky L. S., Gray J. A. and Kerwin R. W. (1995) Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schiz. Res. 17: 95-107.
21. Groenewegen H. J., Vermeulen-Van Der Zee E., Te Kortschot A. and Witter M. P. (1987) Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of phaseolus vulgaris leucoagglutinin. Neuroscience 23: 103-120.
22. Guan X. M. and McBride W. J. (1989) Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res. Bull. 23: 541-547.
23. Hemsley D. R. (1994) Cognitive disturbance as the link between schizophrenic symptoms and their biological bases. Neurol. Psychiat. Brain Res. 2: 163-170.
24. Hervé D., Simon H., Blanc G., Le Moal M., Glowinski J. and Tassin J. P. (1981) Opposite changes in dopamine utilization in the nucleus accumbens and the frontal cortex after electrolytic lesion of the median raphe in the rat. Brain Res. 216: 422-428.
25. Hervé D., Simon H., Blanc G., Lisoprawski A., Le Moal M., Glowinski J. and Tassin J. P. (1979) Increased utilization of dopamine in the nucleus accumbens but not in the cerebral cortex after dorsal raphe lesion in the rat. Neurosci. Lett. 15: 127-133.
26. Imperato A., Scrocco M. G., Bacchi S. and Angelucci L. (1990a) NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur. J. Pharmacol. 187: 555-556.
27. Imperato A., Honoré T. and Jensen L. H. (1990b) Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely moving rats. Brain Res. 530: 223-228.
28. Joseph M. H., Peters S. L. and Gray J. A. (1993) Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure. Psychopharmacology 110: 187-192.
29. Leviel V., Gobert A. and Guibert B. (1990) The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function. Neuroscience 39: 305-312.
30. Lipska B. K., Jaskiw G. E., Chrapusta S., Karoum F. and Weinberger D. R. (1992) Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat. Brain Res. 585: 1-6.
31. Lubow R. E. and Moore A. U. (1959) Latent inhibition: the effect of non-reinforced pre-exposure to the conditioned stimulus. J. Comp. Physiol. Psychol. 52: 415-419.
32. Martin G. R. and Humphrey P. P. A. (1994) Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology 33: 261-273.
33. Melzer H. Y. (1991) Dopaminergic and serotoninergic mechanisms in the action of clozapine. In: Advances in Neuropsychiatry and Psychopharmacology, Vol 1: Schizophrenia Research (Tamminga C. A. and Schultz S. C., Eds.), Raven Press, New York.
34. Meredith G. E., Wouterlood F. G. and Pattiselanno A. (1990) Hippocampal fibers make synaptic contacts with glutamate decarboxylase-immunoreactive neurons in the rat nucleus accumbens. Brain Res. 513: 329-334.
35. Paxinos G. and Watson C. (1987) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
36. Peters S. L. and Joseph M. H. (1993) Haloperidol potentiation of latent inhibition in rats: evidence for a critical role at conditioning rather than pre-exposure. Behav. Pharmacol. 4: 183-186.
37. Schmajuk N. A., Lam Y. W. and Christiansen B. A. (1994) Latent inhibition of the rat eyeblink response: effect of hippocampal aspiration lesions. Phys. Behav. 55: 597-601.
38. Sesack S. R. and Pickel V. M. (1990) In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res. 527: 266-279.
39. 1A autoreceptor. J. Neurosci. Meth. 34: 83-90.
40. Sherman A. D., Davidson A. T., Baruah S., Hegwood T. S. and Waziri R. (1991) Evidence of glutamatergic deficiency in schizophrenia. Neurosci. Lett. 121: 77-80.
41. 1A autoreceptors on serotonergic neurons in the midbrain raphe nuclei. Eur. J. Neurosci. 2: 1144-1154.
42. Tarrasch R., Weiner I., Rawlins J. N. P. and Feldon J. (1992) Disruption of latent inhibition by interrupting the subicular input to the nucleus accumbens and its antagonism by haloperidol. J. Psychopharmacol 6: 111.
43. Weiner I. (1990) Neural substrates of latent inhibition: the switching model. Psychol. Bull. 108: 442-461.
44. Weiner I., Lubow R. E. and Feldon J. (1988) Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol. Biochem. Behav. 30: 871-878.
45. Wheeler D., Boutelle M. G. and Fillenz M. (1995) The role of N-methyl-D-aspartate receptors in the regulation of physiologically released dopamine. Neuroscience 65: 767-774.
46. Woolley D. W. and Shaw E. (1954) A biochemical and pharmacological suggestion about certain mental disorder. Proc. Natn. Acad. Sci. U.S.A. 40: 228-231.
47. Wu M. and Brudzynski S. M. (1995) Mesolimbic dopamine terminals and locomotor activity induced from the subiculum. NeuroReport 6: 1601-1604.
48. Yoshimoto K. and McBride W. J. (1992) Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat. Neurochem. Res. 17: 401-407.